Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma
International Journal of Molecular Sciences · 17.11.2025 · 26 (22) · 11112
DOI: 10.3390/ijms262211112 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.11.2025. Verfasst von María Riaza Montes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Galdakao-Usansolo University Hospital, 48960 Usansolo, Spain. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Gelatinases, Kidney Neoplasms, Serine Endopeptidases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basque Government, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Despite advances in the management of advanced clear cell renal cell carcinoma (ccRCC), robust biomarkers for prognosis and therapeutic response prediction remain elusive. Fibroblast activation protein-α (FAP), a marker of activated cancer-associated fibroblasts (CAFs), has emerged as a potential indicator of tumor aggressiveness and resistance to systemic therapies in various solid tumors. This study evaluated the clinical relevance of stromal FAP expression in a cohort of 137 patients with advanced ccRCC and long-term follow-up. FAP immunohistochemistry (IHC) was performed on primary tumor specimens and correlated with key clinicopathological features, disease-free survival (DFS), overall survival (OS), and radiological response to first-line tyrosine kinase inhibitors (TKIs). A significantly higher percentage of FAP-positive CAFs was observed in primary tumors with high histological grade, extensive local invasion (pT3–4), and advanced clinical stage (NCCN stage III–IV). Stromal FAP expression was associated with shorter DFS and OS. Moreover, tumors lacking FAP expression were more likely to achieve complete response to TKI therapy as defined by RECIST criteria. These findings highlight the potential of FAP IHC as a prognostic and predictive tool in advanced ccRCC and support further clinical validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Galdakao-Usansolo University Hospital, 48960 Usansolo, Spain.
- Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.
- Department of Nursing, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
- Pathology Department, Cruces University Hospital, 48903 Barakaldo, Spain.
- Department of Urology, Cruces University Hospital, 48903 Barakaldo, Spain.
- Molecular Oncology Group, Biogipuzkoa Health Research Institute, 20014 San Sebastián, Spain.
ORCID-Profile: María Riaza Montes, Beatriz Suárez, David Lecumberri, Ane Miren Iturregui, Charles H Lawrie, María Armesto, Caroline E Nunes-Xavier, Rafael Pulido, José I López, Javier C Angulo, Gorka Larrinaga
Förderung
- Basque Government
- Instituto de Salud Carlos III
Zitieren
APA
Riaza Montes, M., Suárez, B., Solano-Iturri, J. D., Lecumberri, D., Iturregui, A. M., Lawrie, C. H., Armesto, M., Nunes-Xavier, C. E., Pulido, R., López, J. I., Angulo, J. C., & Larrinaga, G. (2025). Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences, 26(22), 11112. https://doi.org/10.3390/ijms262211112
Vancouver
Riaza Montes M, Suárez B, Solano-Iturri JD, Lecumberri D, Iturregui AM, Lawrie CH, et al. Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences. 2025;26(22):11112. doi:10.3390/ijms262211112
BibTeX
@article{RiazaMontes2025,
author = {Riaza Montes, María and Suárez, Beatriz and Solano-Iturri, Jon Danel and Lecumberri, David and Iturregui, Ane Miren and Lawrie, Charles H and Armesto, María and Nunes-Xavier, Caroline E and Pulido, Rafael and López, José I and Angulo, Javier C and Larrinaga, Gorka},
title = {Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {22},
pages = {11112},
doi = {10.3390/ijms262211112}
}
EUVIMED